| |
| |
|
| Insider
Information: |
Cohen Chad M |
| Relationship: |
Director |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
230,845 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$158,434 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
230,845 |
|
|
| Total
Value |
$158,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 44.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Zillow Group Inc |
Z |
CFO & Treasurer |
2015-02-18 |
183 |
2015-02-17 |
0 |
Premium* |
|
|
Trupanion Inc. |
TRUP |
Director |
2019-03-31 |
4,119 |
2018-03-31 |
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Chief Financial Officer |
2021-12-22 |
21,604 |
2019-07-01 |
0 |
Premium* |
|
|
Vacasa, Inc. |
VCSA |
Director |
2023-05-23 |
204,939 |
2022-05-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VCSA |
Vacasa, Inc. |
Director |
– • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
170,940 |
204,939 |
0 |
- |
|
| VCSA |
Vacasa, Inc. |
Director |
– • – |
2022-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
33,999 |
33,999 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-12-22 |
4 |
AS |
$30.00 |
$300,000 |
D/D |
(10,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-12-22 |
4 |
OE |
$7.27 |
$72,700 |
D/D |
10,000 |
31,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-11-10 |
4 |
AS |
$33.93 |
$169,650 |
D/D |
(5,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-11-10 |
4 |
OE |
$7.27 |
$36,350 |
D/D |
5,000 |
26,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-11-09 |
4 |
OE |
$7.27 |
$36,350 |
D/D |
5,000 |
26,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-11-09 |
4 |
AS |
$36.03 |
$180,150 |
D/D |
(5,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-10-06 |
4 |
AS |
$32.30 |
$161,500 |
D/D |
(5,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-10-06 |
4 |
OE |
$7.27 |
$36,350 |
D/D |
5,000 |
26,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-10-05 |
4 |
AS |
$32.51 |
$162,550 |
D/D |
(5,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-10-05 |
4 |
OE |
$7.27 |
$36,350 |
D/D |
5,000 |
26,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-09-08 |
4 |
OE |
$7.27 |
$36,350 |
D/D |
5,000 |
26,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-09-08 |
4 |
AS |
$39.01 |
$195,050 |
D/D |
(5,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-09-07 |
4 |
AS |
$39.71 |
$372,281 |
D/D |
(9,375) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-09-07 |
4 |
OE |
$6.55 |
$61,406 |
D/D |
9,375 |
30,979 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-08-11 |
4 |
AS |
$33.48 |
$336,049 |
D/D |
(10,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-08-11 |
4 |
OE |
$6.55 |
$65,500 |
D/D |
10,000 |
31,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-08-10 |
4 |
OE |
$6.55 |
$32,750 |
D/D |
5,000 |
26,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-08-10 |
4 |
AS |
$35.00 |
$175,000 |
D/D |
(5,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-07-07 |
4 |
OE |
$6.55 |
$65,500 |
D/D |
10,000 |
31,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-07-07 |
4 |
AS |
$38.17 |
$385,319 |
D/D |
(10,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-07-06 |
4 |
AS |
$38.83 |
$388,300 |
D/D |
(10,000) |
21,604 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-07-06 |
4 |
OE |
$6.55 |
$65,500 |
D/D |
10,000 |
31,604 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Chief Financial Officer |
• – – |
2021-06-09 |
4 |
OE |
$6.55 |
$65,500 |
D/D |
10,000 |
31,604 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
